Liminatus Pharma and Iris Acquisition Corp Announce Completion of Business Combination
Liminatus (NASDAQ:LIMN) LA PALMA, CA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- Liminatus Pharma, LLC (“Liminatus” or the “Company”), a pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies, …